<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-MedLine.d17">
    <sentence id="DDI-MedLine.d17.s0" text="In vitro interaction of prostaglandin F2alpha and oxytocin in placental vessels.&#xa;">
        <entity id="DDI-MedLine.d17.s0.e0" charOffset="24-44"
            type="drug" text="prostaglandin F2alpha"/>
        <entity id="DDI-MedLine.d17.s0.e1" charOffset="50-57"
            type="drug" text="oxytocin"/>
        <pair id="DDI-MedLine.d17.s0.p0" e1="DDI-MedLine.d17.s0.e0"
            e2="DDI-MedLine.d17.s0.e1" ddi="true" type="int"/>
    </sentence>
    <sentence id="DDI-MedLine.d17.s1" text="The interaction of prostaglandin F2alpha and synthetic oxytocin on placental vessels was studied in vitro. ">
        <entity id="DDI-MedLine.d17.s1.e0" charOffset="19-39"
            type="drug" text="prostaglandin F2alpha"/>
        <entity id="DDI-MedLine.d17.s1.e1" charOffset="55-62"
            type="drug" text="oxytocin"/>
        <pair id="DDI-MedLine.d17.s1.p0" e1="DDI-MedLine.d17.s1.e0"
            e2="DDI-MedLine.d17.s1.e1" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d17.s2" text="Resistance was measured near the placental margin after spontaneous term delivery. "/>
    <sentence id="DDI-MedLine.d17.s3" text="In seven experiments reactions to norepinephrine and oxytocin were PGF2alpha. ">
        <entity id="DDI-MedLine.d17.s3.e0" charOffset="34-47"
            type="drug" text="norepinephrine"/>
        <entity id="DDI-MedLine.d17.s3.e1" charOffset="53-60"
            type="drug" text="oxytocin"/>
        <entity id="DDI-MedLine.d17.s3.e2" charOffset="67-75"
            type="drug" text="PGF2alpha"/>
        <pair id="DDI-MedLine.d17.s3.p0" e1="DDI-MedLine.d17.s3.e0"
            e2="DDI-MedLine.d17.s3.e1" ddi="false"/>
        <pair id="DDI-MedLine.d17.s3.p1" e1="DDI-MedLine.d17.s3.e0"
            e2="DDI-MedLine.d17.s3.e2" ddi="false"/>
        <pair id="DDI-MedLine.d17.s3.p2" e1="DDI-MedLine.d17.s3.e1"
            e2="DDI-MedLine.d17.s3.e2" ddi="false"/>
    </sentence>
    <sentence id="DDI-MedLine.d17.s4" text="PGF2alpha produced significantly increased vasoconstriction after a single administration of oxytocin. ">
        <entity id="DDI-MedLine.d17.s4.e0" charOffset="0-8" type="drug" text="PGF2alpha"/>
        <entity id="DDI-MedLine.d17.s4.e1" charOffset="93-100"
            type="drug" text="oxytocin"/>
        <pair id="DDI-MedLine.d17.s4.p0" e1="DDI-MedLine.d17.s4.e0"
            e2="DDI-MedLine.d17.s4.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-MedLine.d17.s5" text="In eight experiments the perfusion medium contained oxytocin. ">
        <entity id="DDI-MedLine.d17.s5.e0" charOffset="52-59"
            type="drug" text="oxytocin"/>
    </sentence>
    <sentence id="DDI-MedLine.d17.s6" text="There was no change after a single dose of PGF2alpha. ">
        <entity id="DDI-MedLine.d17.s6.e0" charOffset="43-51"
            type="drug" text="PGF2alpha"/>
    </sentence>
    <sentence id="DDI-MedLine.d17.s7" text="The reaction after norepinephrine remained the same in both groups of experiments. ">
        <entity id="DDI-MedLine.d17.s7.e0" charOffset="19-32"
            type="drug" text="norepinephrine"/>
    </sentence>
    <sentence id="DDI-MedLine.d17.s8" text="There is thus an enhancement effect "/>
    <sentence id="DDI-MedLine.d17.s9" text="There is thus an enhancement effect of PGF2alpha upon the reaction of placental vessels to oxytocin in vitro.">
        <entity id="DDI-MedLine.d17.s9.e0" charOffset="39-47"
            type="drug" text="PGF2alpha"/>
        <entity id="DDI-MedLine.d17.s9.e1" charOffset="91-98"
            type="drug" text="oxytocin"/>
        <pair id="DDI-MedLine.d17.s9.p0" e1="DDI-MedLine.d17.s9.e0"
            e2="DDI-MedLine.d17.s9.e1" ddi="true" type="effect"/>
    </sentence>
</document>
